Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;62(2):306-311.
doi: 10.1111/ajo.13466. Epub 2021 Dec 4.

A survey study of endometrial receptivity tests and immunological treatments in in vitro fertilisation (IVF)

Violet Kieu  1   2   3 , Daniel Lantsberg  1   2   3 , Yossi Mizrachi  1 , Catharyn Stern  1   2   3 , Alex Polyakov  1   2   3 , Wan Tinn Teh  1   2   3
Affiliations

A survey study of endometrial receptivity tests and immunological treatments in in vitro fertilisation (IVF)

Violet Kieu et al. Aust N Z J Obstet Gynaecol. 2022 Apr.

Abstract

Background: Suboptimal endometrial receptivity is a key factor behind in vitro fertilisation (IVF) implantation failure. Direct clinical tests of the endometrium of natural killer (NK) cells and endometrial receptivity analysis (ERA) are controversial.

Aims: To examine the current practice of endometrial receptivity tests (NK cells and ERA) and immunological treatments (corticosteroids, anticoagulants, antiplatelets, intravenous immunoglobulin, Intralipid, other) among fertility specialists in Australia and New Zealand.

Methods: A prospective 23-item web-based survey was distributed by email via the Fertility Society of Australia and New Zealand, between August and October 2020. Data were collected and analysed using Qualtrics.

Results: Of 238 fertility specialists, 90 completed the survey (response rate 37.8%). ERA (48/90, 53.3%) was most commonly ordered, followed by uterine NK (uNK) (36/90, 40.0%) and peripheral blood NK (pNK) (12/90, 13.3%). For all tests, the most common indication was recurrent implantation failure (RIF) (41/48, 22/36, 6/12; 85.4%, 61.1%, and 50.0%, respectively for ERA, uNK and pNK). Of those that did not offer these tests, the main reason cited was insufficient evidence (30/42, 47/54, 68/78; 71.4%, 87.0%, and 87.0%). A third of specialists offered empirical immunological treatment for RIF (30/90, 33.3%): anticoagulants (28/30, 93.3%), antiplatelets (27/30, 90.0%), and corticosteroids (25/30; 83.3%). The majority of specialists (56/90, 62.2%) stated they had refused a patient request for endometrial testing or treatment.

Conclusions: Tests for presumed endometrial receptivity pathology are often used in Australia and New Zealand. Immunological treatments for RIF are commonly employed empirically, without strong evidence of their effectiveness or safety. Further studies should focus on education and clinical adherence to evidence-based guidelines.

Keywords: endometrial receptivity; endometrial receptivity analysis; immunological therapies; peripheral blood natural killer cells; uterine natural killer cells.

PubMed Disclaimer

References

    1. Lessey BA, Young SL. What exactly is endometrial receptivity? Fertil Steril 2019; 111: 611-617.
    1. Teh WT, McBain J, Rogers P. What is the contribution of embryo-endometrial asynchrony to implantation failure? J Assist Reprod Genet 2016; 33: 1419-1430.
    1. Aghajanova L, Hamilton AE, Giudice LC. Uterine receptivity to human embryonic implantation: histology, biomarkers, and transcriptomics. Semin Cell Dev Biol 2008; 19(2): 204-211.
    1. Simón C, Gómez C, Cabanillas S et al. A 5-year multicentre randomized controlled trial comparing personalized, frozen and fresh blastocyst transfer in IVF. Reprod Biomed Online 2020; 41: 402-415.
    1. Kwak-Kim J, Han AR, Gilman-Sachs A et al. Current trends of reproductive immunology practices in in vitro fertilization (IVF) - a first world survey using IVF-Worldwide.com. Am J Reprod Immunol 2013; 69(1): 12-20.

LinkOut - more resources